# Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy

Study · id `cardio:ct-nct01293903` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01293903](<https://clinicaltrials.gov/study/NCT01293903>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01293903

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 374 participants.

## Technical summary

Registry record NCT01293903. Randomized; quadruple masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2015-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 374 participants (enrolled count; ClinicalTrials.gov record NCT01293903, source copy `cardio:ctgov-nct01293903-2017-08-29`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01293903, source copy `cardio:ctgov-nct01293903-2017-08-29`, retrieved 2026-10-26)
- Primary completion: 2015-12-31 (actual) (ClinicalTrials.gov record NCT01293903, source copy `cardio:ctgov-nct01293903-2017-08-29`, retrieved 2026-10-26)
- Completion: 2016-09-30 (actual) (ClinicalTrials.gov record NCT01293903, source copy `cardio:ctgov-nct01293903-2017-08-29`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01293903, source copy `cardio:ctgov-nct01293903-2017-08-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01293903-2017-08-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy
- Acronym: QLQX-DCM
- Condition: Dilated Cardiomyopathy
- Condition: Heart Failure
- Intervention (Drug): Qiliqiangxin capsule
- Intervention (Drug): Placebo
- Lead sponsor: Huazhong University of Science and Technology
- Lead sponsor class: OTHER
- Collaborator: Fudan University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital Xi'an Jiaotong University
- Collaborator class: OTHER
- Collaborator: Shandong Provincial Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: The First Affiliated Hospital with Nanjing Medical University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Guangxi Medical University
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Zhengzhou University
- Collaborator class: OTHER
- Collaborator: Ministry of Science and Technology of the People´s Republic of China
- Collaborator class: OTHER\_GOV
- Collaborator: China National Center for Cardiovascular Diseases
- Collaborator class: OTHER\_GOV
- Collaborator: RenJi Hospital
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Xi'an Jiaotong University
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER
- Collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Collaborator class: OTHER
- Collaborator: Tongji Hospital
- Collaborator class: OTHER
- Collaborator: Wuhan University
- Collaborator class: OTHER
- Collaborator: Henan Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: Jining Medical University
- Collaborator class: OTHER
- Collaborator: Second Hospital of Shanxi Medical University
- Collaborator class: OTHER
- Collaborator: Shanxi Cardiovascular Hospital
- Collaborator class: OTHER
- Collaborator: Wuhan Pu-Ai Hospital
- Collaborator class: OTHER
- Collaborator: Tianyou Hospital Affiliated to Wuhan University of Science and Technology
- Collaborator class: OTHER
- Collaborator: Yunyang Medical College
- Collaborator class: OTHER
- Collaborator: China Three Gorges University, Yichang, China
- Collaborator class: OTHER
- Collaborator: Xiangyang Central Hospital
- Collaborator class: OTHER
- Collaborator: Wuhan No.1 Hospital
- Collaborator class: OTHER
- Collaborator: Jingzhou Central Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Dilated cardiomyopathy (`cardio:dilated-cardiomyopathy`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 22 registry organizations

## Provenance

Content hash: 73936f87038b0026b6452b2c7119b0caf8fcf2e744639cd659eb82eab068749e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
